Darren K. McGuire, MD, MHSc; Frans Van de Werf, MD, PhD; Paul W. Armstrong, MD; et al.
free access
has audio
JAMA Cardiol. 2016;1(2):126-135. doi:10.1001/jamacardio.2016.0103
This secondary analysis of the Trial Evaluating Cardiovascular Outcomes With Sitagliptin (TECOS) assesses the association of sitagliptin use with hospitalization for heart failure and related outcomes among patients with type 2 diabetes mellitus and atherosclerotic vascular disease.
-
Podcast:
DPP4 Inhibitors for Diabetes and the Risk for Heart Failure (JAMA Cardiology)
-
Editorial
The Safety of Dipeptidyl Peptidase 4 Inhibitors and the Risk for Heart Failure
Benjamin M. Scirica, MD, MPH
JAMA Cardiol
-
Podcast:
DPP4 Inhibitors for Diabetes and the Risk for Heart Failure (JAMA Cardiology)
Sagar B. Dugani, MD, PhD; Akintunde O. Akinkuolie, MBBS, MPH; Nina Paynter, PhD; et al.
free access
JAMA Cardiol. 2016;1(2):136-145. doi:10.1001/jamacardio.2016.0096
This secondary analysis of the JUPITER randomized clinical trial investigates the association of lipoprotein subclasses and size and insulin resistance with incident type 2 diabetes mellitus in individuals randomized to a high-intensity statin.
-
Invited Commentary
The Enigma of Glucose and Lipid Metabolism
Neha J. Pagidipati, MD, MPH; Michael Pencina, PhD; Allan D. Sniderman, MD
JAMA Cardiol
Kamil F. Faridi, MD; Eric D. Peterson, MD, MPH; Lisa A. McCoy, MS; et al.
free access
JAMA Cardiol. 2016;1(2):147-155. doi:10.1001/jamacardio.2016.0001
This observational study uses the Acute Coronary Treatment and Intervention Network Registry鈥揋et With the Guidelines (ACTION Registry鈥揋WTG) linked with Medicare Part D prescription fill data to examine the association between follow-up time and adherence to medications prescribed after acute myocardial infarction in Medicare-insured patients.
Yariv Gerber, PhD; Susan A. Weston, MS; Maurice Enriquez-Sarano, MD; et al.
free access
JAMA Cardiol. 2016;1(2):156-162. doi:10.1001/jamacardio.2016.0074
This population-based study examines the association between the extent of coronary artery disease present after myocardial infarction and the development of heart failure.
H. Kirk Hammond, MD; William F. Penny, MD; Jay H. Traverse, MD; et al.
open access
JAMA Cardiol. 2016;1(2):163-171. doi:10.1001/jamacardio.2016.0008
This randomized clinical trial evaluates the effect of gene transfer through intracoronary administration of adenovirus 5 encoding adenylyl cyclase 6 on left ventricular function in patients with heart failure.
Fredrik Björck, MD; Henrik Renlund, PhD; Gregory Y. H. Lip, MD, PhD; et al.
free access
JAMA Cardiol. 2016;1(2):172-180. doi:10.1001/jamacardio.2016.0199
This cohort study evaluates the safety and efficacy of warfarin, with and without concomitant aspirin, in prophylaxis of stroke associated with atrial fibrillation.
Faisal M. Merchant, MD; Michael H. Hoskins, MD; Michael E. Benser, PhD; et al.
free access
JAMA Cardiol. 2016;1(2):181-188. doi:10.1001/jamacardio.2015.0386
This cohort study investigates the time course of subsequent shocks after an initial implantable cardioverter-defibrillator (ICD) discharge in a national population of implant recipients.
Paul S. Chan, MD, MSc; Sarah L. Krein, PhD, RN; Fengming Tang, MS; et al.
free access
JAMA Cardiol. 2016;1(2):189-197. doi:10.1001/jamacardio.2016.0073
This study identifies resuscitation practices associated with higher rates of in-hospital cardiac arrest survival.
Joseph L. Blackshear, MD; Chad W. McRee, MD; Robert E. Safford, MD, PhD; et al.
free access
JAMA Cardiol. 2016;1(2):198-204. doi:10.1001/jamacardio.2016.0075
This cohort study determines whether dysfunctional valve prostheses are associated with von Willebrand factor abnormalities, identifies their severity relative to other conditions, and describes associated bleeding and the occurrence of gastrointestinal angiodysplasia.